Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction
{{output}}
Giant congenital melanocytic nevus (GCMN) is a RAS/RAF mutation-driven syndrome characterized by extensive melanocytic lesions, posing psychological challenges and a lifelong risk of malignancy. Existing treatments like surgical resection and laser therapy fai... ...
